Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

The efficacy of retreatment with immunomodulatory drugs (IMiDs) among patients with multiple myeloma who received this class of drugs for initial therapy is unknown. We studied 140 patients who received either thalidomide-dexamethasone (81; 58%) or lenalidomide-dexamethasone (59; 42%) as first-line...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Madan, Sumit, Lacy, Martha Q., Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis, Hayman, Suzanne R., Detweiler-Short, Kristen, Dingli, David, Zeldenrust, Steven, Lust, John, Greipp, Philip R., Rajkumar, S. Vincent, Kumar, Shaji
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2011
Soggetti:
Clinical Trials and Observations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3158710/
https://ncbi.nlm.nih.gov/pubmed/21673347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-350009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi